Mohite Ajay A, Perais Jennifer A, McCullough Philip, Lois Noemi
Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast BT12 6BA, UK.
Welcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, UK.
J Clin Med. 2023 Mar 21;12(6):2406. doi: 10.3390/jcm12062406.
Retinal ischaemia is present to a greater or lesser extent in all eyes with diabetic retinopathy (DR). Nonetheless, our understanding of its pathogenic mechanisms, risk factors, as well as other characteristics of retinal ischaemia in DR is very limited. To date, there is no treatment to revascularise ischaemic retina.
Review of the literature highlighting the current knowledge on the topic of retinal ischaemia in DR, important observations made, and underlying gaps for which research is needed.
A very scarce number of clinical studies, mostly cross-sectional, have evaluated specifically retinal ischaemia in DR. Interindividual variability on its natural course and consequences, including the development of its major complications, namely diabetic macular ischaemia and proliferative diabetic retinopathy, have not been investigated. The in situ, surrounding, and distance effect of retinal ischaemia on retinal function and structure and its change over time remains also to be elucidated. Treatments to prevent the development of retinal ischaemia and, importantly, to achieve retinal reperfusion once capillary drop out has ensued, are very much needed and remain to be developed.
Research into retinal ischaemia in diabetes should be a priority to save sight.
在所有患有糖尿病视网膜病变(DR)的眼睛中,或多或少都存在视网膜缺血。然而,我们对其致病机制、危险因素以及DR中视网膜缺血的其他特征的了解非常有限。迄今为止,尚无使缺血性视网膜血管再生的治疗方法。
回顾文献,突出显示有关DR中视网膜缺血主题的当前知识、所做的重要观察以及需要进行研究的潜在空白。
非常少的临床研究(大多为横断面研究)专门评估了DR中的视网膜缺血。尚未研究其病程和后果的个体间差异,包括其主要并发症即糖尿病性黄斑缺血和增殖性糖尿病视网膜病变的发生情况。视网膜缺血对视网膜功能和结构的原位、周围及远距离影响及其随时间的变化仍有待阐明。非常需要开发预防视网膜缺血发展的治疗方法,重要的是,在毛细血管闭塞后实现视网膜再灌注的治疗方法仍有待开发。
糖尿病视网膜缺血的研究应成为挽救视力的优先事项。